Novavax Reports Promising Q2 2024 Results with Sanofi Partnership
Novavax, Inc. has released its second quarter financial results for 2024, showcasing a promising future thanks to a strategic partnership with Sanofi. This collaboration is primarily responsible for the reported revenue of $415 million, offering a significant financial boost, largely from an upfront payment from the partnership.
Exclusive Access: Unlock Premium, Confidential Insights
Unlock This Exclusive Content—Subscribe Instantly!
Login if you have purchased
